Gilead Sciences (GILD) Change in Cash (2009 - 2026)

Gilead Sciences (GILD) has reported Change in Cash for 18 consecutive years, with $65.0 million the latest figure, recorded in Q1 2026.

• Change in Cash for Q1 2026 came in at $65.0 million, up 103.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$298.0 million (down 109.29% YoY), and the FY2025 annual result was -$2.4 billion, down 162.16% from the prior year.
• Change in Cash was $65.0 million for Q1 2026 at Gilead Sciences, down from $233.0 million in the prior quarter.
• Over five years, Change in Cash peaked at $5.0 billion in Q4 2024 and troughed at -$2.8 billion in Q2 2025.
• Average Change in Cash over 5 years is $134.7 million, with a median of $65.0 million recorded in 2026.
• The widest YoY moves for Change in Cash: up 226300.0% in 2024, down 353.39% in 2024.
• Over 5 years, Change in Cash stood at $713.0 million in 2022, then tumbled by 46.7% to $380.0 million in 2023, then surged by 1203.95% to $5.0 billion in 2024, then sank by 95.3% to $233.0 million in 2025, then slumped by 72.1% to $65.0 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $65.0 million in Q1 2026, $233.0 million in Q4 2025, and $2.2 billion in Q3 2025.